Yahoo
OTC Markets OTCID USD

Lee Pharmaceuticals, Inc. (AIMN)

0.0014 0.0000 (0.00%)
At close: August 19 at 3:13:21 PM EDT
Chart Range Bar
Loading chart for AIMN
  • Previous Close 0.0014
  • Open 0.0014
  • Bid 0.0012 x 61000000
  • Ask 0.0014 x 2000000
  • Day's Range 0.0014 - 0.0014
  • 52 Week Range 0.0011 - 12.0000
  • Volume 10,765
  • Avg. Volume 1,957,307
  • Market Cap (intraday) 462,191
  • Beta (5Y Monthly) 976.42
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Lee Pharmaceuticals, Inc. provides personal care products in the United States. The company offers aloe vera products, antacids, cosmetics and douches, cough and cold products, depilatories and waxes, laxatives, lip balm products, men's personal care products, monticello drugs, oral care products, pain relievers, skin care products, tobacco accessories, topical ointments and creams, baby care products, and vitamins and nutritional products, as well as nasal sprays, lip conditioners, and over the counter products. It also provides private label and contract manufacturing services. The company was founded in 1971 and is based in Mobile, Alabama.

--

Full Time Employees

December 31

Fiscal Year Ends

Shell Companies

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 8/19/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AIMN
99.98%
S&P 500 (^GSPC)
12.60%

1-Year Return

AIMN
99.98%
S&P 500 (^GSPC)
20.22%

3-Year Return

AIMN
100.00%
S&P 500 (^GSPC)
76.40%

5-Year Return

AIMN
100.00%
S&P 500 (^GSPC)
74.95%

Statistics

View More

Valuation Measures

Annual
As of 8/18/2026
  • Market Cap

    462.19k

  • Enterprise Value

    462.19k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -1,670.94%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -505.11k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.17k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: